Generic Name and Formulations:
Carisoprodol 200mg, aspirin 325mg; tabs.
Various generic manufacturers
Indications for Carisoprodol/Aspirin:
Painful musculoskeletal conditions.
1–2 tabs 4 times daily.
NSAID allergy. Varicella or influenza in teenagers. Coagulation disorders. Porphyria.
Peptic ulcer. Gastritis. Renal or hepatic dysfunction. Drug abuse. Monitor blood pressure, BUN, uric acid levels. Elderly. Debilitated. Pregnancy (Cat.C). Nursing mothers: not recommended.
Alcohol, CNS depressants, oral anticoagulants, hypoglycemics, and plasma bound drugs (e.g., methotrexate) potentiated. NSAIDs, corticosteroids and oral anticoagulants increase risk of GI bleeding. Uricosurics antagonized. Urine alkalinizers or acidifiers decrease or increase, respectively, plasma levels of aspirin.
Muscle relaxant (central) + salicylate.
Dizziness, drowsiness, GI upset or bleeding, rash, tachycardia, orthostatic hypotension. Rare idiosyncratic reaction (see literature).
Formerly known under the brand name Soma Compound.
Psychiatry Advisor Articles
- Continuing Research, Emerging Treatments Hold Promise for Treating Anorexia Nervosa
- ACOG Update: Marijuana Use Discouraged During Pregnancy, Breastfeeding
- Asenapine Prevents Recurrence of Mood Events in Bipolar Disorder
- Venlafaxine XR Safe, Effective in Treating Generalized Anxiety Disorder
- Duration of Untreated Depression Predicts Depression Severity
- CBT, Acceptance Commitment Therapy Helpful for Those With Chronic Pain
- Suicidal Behavior, Thoughts Associated With Perfectionist Tendencies
- Depression Reduced by Social Belonging, Feelings of Inclusion
- Sleep Disturbance May Be Causal Factor in Psychotic Experiences
- Is Antidepressant Use in Pregnancy Tied to Psychiatric Disorders in Offspring?
- Elevated Dopamine Synthesis Capacity Observed in Both Bipolar and Schizophrenia
- SSRI Use Associated With Increased Type 2 Diabetes Risk in Young Adults
- Specialty Physicians Experiencing Lack of Income Growth
- Improved Patient-Provider Communication Needed Following Urgent Care Visits
- Cardiovascular Risk Management May Slow Neurocognitive Decline in HIV